©The Author(s) 2026.
World J Psychiatry. Jan 19, 2026; 16(1): 112973
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.112973
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.112973
Table 3 Stepwise multiple logistic regression about Self-rating Depression Scale and Self-rating Anxiety Scale total and their subscale scores with botulinum toxin A treatment
- Citation: He XY, Xu MY, Feng LY, Zhang JT, Jin LZ, Jin L, Ge JC, Zhang L, Zhang WB, Zhang L, Shen H, Yan J. Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control. World J Psychiatry 2026; 16(1): 112973
- URL: https://www.wjgnet.com/2220-3206/full/v16/i1/112973.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i1.112973